Dyskinesia News and Research

RSS
Deep brain stimulation may improve survival for Parkinson's patients

Deep brain stimulation may improve survival for Parkinson's patients

Sonic Hedgehog helps solve mysteries of Parkinson's disease

Sonic Hedgehog helps solve mysteries of Parkinson's disease

New approaches to prevent or treat antipsychotic-induced supersensitivity psychosis

New approaches to prevent or treat antipsychotic-induced supersensitivity psychosis

New drug may limit disease progression, provide better symptom relief to Parkinson's patients

New drug may limit disease progression, provide better symptom relief to Parkinson's patients

Apomorphine infusion found to be effective treatment for Parkinson’s patients with motor fluctuations

Apomorphine infusion found to be effective treatment for Parkinson’s patients with motor fluctuations

FDA grants approval for first drug to treat adults with tardive dyskinesia

FDA grants approval for first drug to treat adults with tardive dyskinesia

New drug can reduce tardive dyskinesia in patients with schizophrenia, mood disorder

New drug can reduce tardive dyskinesia in patients with schizophrenia, mood disorder

FDA approves drug as add-on treatment for Parkinson's disease patients

FDA approves drug as add-on treatment for Parkinson's disease patients

New infusion therapy may help avoid debilitating symptoms in Parkinson's disease patients

New infusion therapy may help avoid debilitating symptoms in Parkinson's disease patients

UAB researchers uncover vital mechanism for L-DOPA-induced-dyskinesia

UAB researchers uncover vital mechanism for L-DOPA-induced-dyskinesia

Defects in cerebrospinal fluid flow may contribute to scoliosis during adolescence

Defects in cerebrospinal fluid flow may contribute to scoliosis during adolescence

Neurocrine Biosciences reports net loss of $29.3 million for fourth quarter 2015

Neurocrine Biosciences reports net loss of $29.3 million for fourth quarter 2015

Opicapone simplifies levodopa-related motor fluctuation treatment

Opicapone simplifies levodopa-related motor fluctuation treatment

SynAgile announces positive results from Phase 2a trial of continuous intraoral LD/CD therapy

SynAgile announces positive results from Phase 2a trial of continuous intraoral LD/CD therapy

Neurocrine Biosciences announces positive data from NBI-98854 Phase III trial in tardive dyskinesia

Neurocrine Biosciences announces positive data from NBI-98854 Phase III trial in tardive dyskinesia

Invitae announces dramatic expansion of genetic testing menu

Invitae announces dramatic expansion of genetic testing menu

Study reveals why long-term use of L-DOPA leads to dyskinesia

Study reveals why long-term use of L-DOPA leads to dyskinesia

University of Maryland Medicine offers MRI-guided focused ultrasound treatment to Parkinson's patients

University of Maryland Medicine offers MRI-guided focused ultrasound treatment to Parkinson's patients

Researchers perform first focused ultrasound treatments in the U.S. for dyskinesia

Researchers perform first focused ultrasound treatments in the U.S. for dyskinesia

Putaminal serotonergic innervation flags levodopa-induced dyskinesia risk

Putaminal serotonergic innervation flags levodopa-induced dyskinesia risk